Fig. 2
From: IGF2BP3 prevent HMGB1 mRNA decay in bladder cancer and development
High IGF2BP3 expression correlated with unfavorable outcomes in bladder cancer patients. A–C Kaplan–Meier analysis of OS, DSS, and PFI according to IGF2BP3 expression in TCGA BLCA. D, E Kaplan–Meier analysis of OS and DFS according to IGF2BP3 expression in GSE1827. F, G Kaplan–Meier analysis of OS and DSS according to IGF2BP3 expression in GSE48276. H Kaplan–Meier analysis of DSS according to IGF2BP3 expression in GSE32894. I Kaplan–Meier analysis of PFS for patients with early-stage bladder cancer according to IGF2BP3 expression in E-MTAB-4321. OS, overall survival; DSS, disease specific survival, progression free interval (PFI), disease free survival (DFS), progression-free survival (PFS)